As consumers increasingly lean toward moderation, Fever-Tree is strategically positioned to meet this emerging trend. Known for its premium mixers, the company is experiencing growth thanks to expanding market opportunities.
Financial Performance Overview
Fever-Tree reported a total adjusted revenue of £375.3 million for the year 2025, marking a 2% increase compared to the previous year.
The increase can be attributed to a 3% growth in the US market, generating revenues of £131.9 million.
The firm has also benefitted from a strategic distribution partnership with Molson Coors, a leading US brewing company, which has been progressing according to expectations.
In contrast, the UK market saw a slight decline in revenues, which fell by 2% to £108.4 million for the year.
However, Fever-Tree noted an uptick in trading during the second half of 2025, particularly in retail settings, including supermarkets.
Furthermore, the brand is gaining “increasing momentum” in its premium soft drinks segment, moving beyond its traditional focus on tonics.
Future Outlook
Fever-Tree is on pace for revenues and adjusted earnings that are expected to be “marginally ahead of current market expectations.”
Tim Warrillow, the CEO of Fever-Tree, stated, “We made excellent progress in 2025.”
He added, “Our partnership with Molson Coors in the US is progressing well, and the momentum behind the brand is especially encouraging, giving us confidence in the growing opportunity in our largest market as execution moves beyond the transition phase.”
Mr. Warrillow emphasized that Fever-Tree is committed to building momentum across all markets, transitioning the brand from being solely a premium mixer to also a premium soft drink of choice.
In response to these positive developments, shares in Fever-Tree rose by 3.9% on Thursday morning.
Key Takeaways
- Fever-Tree reported a 2% revenue increase, reaching £375.3 million for 2025.
- The US market contributed to a 3% revenue growth, totaling £131.9 million.
- The company is gaining traction in the premium soft drink segment beyond its core tonic offerings.
- Retail trading showed improvement in the second half of 2025, particularly with supermarkets.
- Fever-Tree’s future earnings are projected to exceed market expectations.
FAQ
What is Fever-Tree known for?
Fever-Tree is renowned for its premium mixers, particularly tonic water.
How did Fever-Tree’s revenues perform in 2025?
The company reported a total adjusted revenue increase of 2%, reaching £375.3 million.
What markets contributed to Fever-Tree’s growth?
The US market was a significant contributor to growth, with a revenue increase of 3%.
What changes are happening in Fever-Tree’s product offerings?
Fever-Tree is expanding its range to include more premium soft drinks in addition to its traditional tonics.
In summary, Fever-Tree is successfully navigating changes in consumer preferences by broadening its product line and forming key partnerships, positioning itself for continued growth.
